An 8-week, multicenter, double-blind, randomized, parallel-group, forced-titration study was conducted to evaluate the antihypertensive efficacy of candesartan vs. losartan in 654 hypertensive ...

The study had long been blocked by the FDA due to the specific ways in which the sponsoring organization wanted to conduct it ...

The company plans to leverage research and development incentives from the Australian Government to offset the trial costs.